Stay updated on Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedUpdates the displayed ClinicalTrials.gov page revision from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded Ono Pharmaceutical Co., Ltd. and Revision: v3.5.2; removed Ono Pharmaceutical Co. Ltd and Revision: v3.5.0.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedLocation entry for Italy 35128 updated from Padua to Padova. Padova, Italy, 35128 is now listed as a site.SummaryDifference0.0%

- Check44 days agoChange DetectedUpdated the location from Napoli, Italy, 80131 to Naples, Italy, 80131. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3; a minor template update with no changes to study details or data.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page revision was updated from v3.4.1 to v3.4.2; this change does not affect the study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.